Author Title [ Type(Asc)] Year
Filters: Author is Chang, Yun  [Clear All Filters]
Journal Article
Jiang Y, Li X, Guo T, Lu W-J, Ma S, Chang Y, Song Y, Zhang S, Bai R, Wang H, et al. Ranolazine rescues the heart failure phenotype of PLN-deficient human pluripotent stem cell-derived cardiomyocytes. Stem Cell Reports. 2022.
Hang C, Song Y, Wu F, Dong T, Jiang M, Saleem A, Zhang S, Chang Y, Lu W, Cui M. Generation of a homozygous COX6A2 knockout human embryonic stem cell line (WAe009-A-47) via an epiCRISPR/Cas9 system. Stem Cell Res. 2021;50:102152.
Chang Y, Hellwarth PB, Randolph LN, Sun Y, Xing Y, Zhu W, Lian XLance, Bao X. Fluorescent Indicators for Continuous and Lineage-Specific Reporting of Cell Cycle Phases in Human Pluripotent Stem Cells. Biotechnol Bioeng. 2020.
Liu X, Zhang S, Chang Y, Wu F, Bai R. Establishment of a KCNQ1 homozygous knockout human embryonic stem cell line by episomal vector-based CRISPR/Cas9 system. Stem Cell Res. 2021;55:102467.
Dong T, Zhang S, Chang Y, Bai R, Jiang Y, Ma S, Li Y'nan, Jiang HFeng, Lu W-J. The establishment of a homozygous SNTA1 knockout human embryonic stem cell line (WAe009-A-50) using the CRISPR/Cas9 system. Stem Cell Res. 2021;51:102196.
Chang Y, Jin G, Luo W, Luo Q, Jung J, Hummel SN, Torregrosa-Allen S, Elzey BD, Low PS, Lian XLance, et al. Engineered human pluripotent stem cell-derived natural killer cells with PD-L1 responsive immunological memory for enhanced immunotherapeutic efficacy. Bioact Mater. 2023;27:168-180.
Harris JD, Chang Y, Syahirah R, Lian XLance, Deng Q, Bao X. Engineered anti-prostate cancer CAR-neutrophils from human pluripotent stem cells. J Immunol Regen Med. 2023;20.
Chang Y, Syahirah R, Oprescu SN, Wang X, Jung J, Cooper SH, Torregrosa-Allen S, Elzey BD, Hsu AY, Randolph LN, et al. Chemically-defined generation of human hemogenic endothelium and definitive hematopoietic progenitor cells. Biomaterials. 2022;285:121569.
Jung J, Chang Y, Jin G, Deng Q, Lian XLance, Bao X. Chemically defined generation of human definitive hematopoietic stem and progenitor cells. STAR Protoc. 2022;4(1):101953.
Chang Y, Cai X, Syahirah R, Yao Y, Xu Y, Jin G, Bhute VJ, Torregrosa-Allen S, Elzey BD, Won Y-Y, et al. CAR-neutrophil mediated delivery of tumor-microenvironment responsive nanodrugs for glioblastoma chemo-immunotherapy. Nat Commun. 2023;14(1):2266.